about
Enzyme replacement therapy for Anderson-Fabry diseaseEnzyme replacement therapy for Anderson-Fabry diseaseA distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapyEffect of reduced agalsidase Beta dosage in fabry patients: the Australian experienceEnzyme replacement therapy for Fabry disease: A systematic review and meta-analysis.Enzyme enhancers for the treatment of Fabry and Pompe disease.
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Enzyme replacement therapy for Anderson-Fabry disease
@ast
Enzyme replacement therapy for Anderson-Fabry disease
@en
Enzyme replacement therapy for Anderson-Fabry disease
@en-gb
Enzyme replacement therapy for Anderson-Fabry disease
@nl
type
label
Enzyme replacement therapy for Anderson-Fabry disease
@ast
Enzyme replacement therapy for Anderson-Fabry disease
@en
Enzyme replacement therapy for Anderson-Fabry disease
@en-gb
Enzyme replacement therapy for Anderson-Fabry disease
@nl
prefLabel
Enzyme replacement therapy for Anderson-Fabry disease
@ast
Enzyme replacement therapy for Anderson-Fabry disease
@en
Enzyme replacement therapy for Anderson-Fabry disease
@en-gb
Enzyme replacement therapy for Anderson-Fabry disease
@nl
P2860
P1476
Enzyme replacement therapy for Anderson-Fabry disease
@en
P2093
Gregory M Pastores
Regina P El Dib
P2860
P356
10.1002/14651858.CD006663.PUB2
P577
2010-05-12T00:00:00Z